Roche (OTCMKTS:RHHVF – Get Free Report) is projected to post its resultson Thursday, July 23rd. Analysts expect Roche to post earnings of $12.51 per share and revenue of $37.6482 billion for the quarter.
Roche Stock Performance
Shares of RHHVF stock opened at $420.37 on Thursday. Roche has a fifty-two week low of $300.15 and a fifty-two week high of $490.33. The stock’s 50-day simple moving average is $408.49 and its 200-day simple moving average is $420.80.
About Roche
Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.
In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.
Featured Articles
- Five stocks we like better than Roche
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
